Literature DB >> 18631336

Progression of tractional retinal detachment following intravitreal bevacizumab.

Jost B Jonas, Matthias Schmidbauer, Florian Rensch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631336     DOI: 10.1111/j.1755-3768.2008.01225.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  15 in total

1.  Bevacizumab prior to vitrectomy for diabetic traction retinal detachment.

Authors:  R Pokroy; U R Desai; E Du; Y Li; P Edwards
Journal:  Eye (Lond)       Date:  2011-07-08       Impact factor: 3.775

Review 2.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF.

Authors:  C-K Chang; C-K Cheng; C-H Peng
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

4.  Effect of bevacizumab on the expression of fibrosis-related inflammatory mediators in ARPE-19 cells.

Authors:  San-Jun Chu; Zhao-Hua Zhang; Min Wang; Hai-Feng Xu
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

Review 5.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

6.  Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.

Authors:  Farzin Forooghian; Peter J Kertes; Kenneth T Eng; Elvira Agrón; Emily Y Chew
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-10       Impact factor: 4.799

7.  From the Hypotheses to Clinical Evidence in Retinal Therapy.

Authors:  Bradley Beatson; J Fernando Arevalo
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

8.  Macular edema formation and deterioration of retinal function after intravitreal bevacizumab injection for proliferative diabetic retinopathy.

Authors:  Hisanori Imai; Shigeru Honda; Yasutomo Tsukahara; Akira Negi
Journal:  Case Rep Ophthalmol       Date:  2011-09-23

9.  Recurrence of macular hole retinal detachment after intravitreal ranibizumab injection for the treatment of choroidal neovascularization from the remaining macular hole edge.

Authors:  Keiko Otsuka; Hisanori Imai; Tsuyoshi Shimoyama; Takayuki Nagai; Shigeru Honda; Atsushi Azumi
Journal:  Case Rep Ophthalmol       Date:  2012-12-18

Review 10.  The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.

Authors:  Gemma Tremolada; Claudia Del Turco; Rosangela Lattanzio; Silvia Maestroni; Anna Maestroni; Francesco Bandello; Gianpaolo Zerbini
Journal:  Exp Diabetes Res       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.